Vesna Sossi Selected Research

Vesna Sossi Research Topics

Disease

53	Parkinson Disease (Parkinson's Disease) 05/2024 - 02/2002
9	Cognitive Dysfunction 05/2024 - 10/2015
9	Parkinsonian Disorders (Parkinsonism) 10/2017 - 12/2005
6	Dyskinesias (Dyskinesia) 01/2023 - 12/2004
5	Disease Progression 04/2024 - 08/2004
4	Bipolar Disorder (Manic Depressive Psychosis) 12/2022 - 05/2002
4	Mania (Manias) 12/2022 - 05/2002
3	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 10/2019
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019 - 02/2012
2	Neuroinflammatory Diseases 05/2024 - 01/2019
2	Atrophy 04/2024 - 01/2023
2	Mixed Dementias 04/2024 - 10/2015
2	Dementia (Dementias) 01/2023 - 10/2013
2	Frontotemporal Dementia (Semantic Dementia) 01/2021 - 10/2013
2	Transient Ischemic Attack 06/2020 - 10/2019
2	Leukoencephalopathies 06/2020 - 10/2019
2	Lacunar Stroke 06/2020 - 10/2019
2	Body Weight (Weight, Body) 01/2020 - 05/2012
2	Neoplasms (Cancer) 03/2018 - 01/2017
1	Cerebral Small Vessel Diseases 04/2024
1	Multiple Sclerosis 12/2022
1	Major Depressive Disorder (Major Depressive Disorders) 01/2018
1	Intellectual Disability (Idiocy) 10/2017
1	Triple Negative Breast Neoplasms 01/2017
1	Breast Neoplasms (Breast Cancer) 01/2017
1	Hypoxia (Hypoxemia) 01/2016
1	Substance-Related Disorders (Drug Abuse) 10/2012
1	Secondary Parkinson Disease (Secondary Parkinsonism) 04/2012
1	Treatment-Resistant Depressive Disorder 06/2010
1	Huntington Disease (Huntington's Disease) 08/2005

Drug/Important Bio-Agent (IBA)

30	Dopamine (Intropin)FDA LinkGeneric 12/2022 - 02/2002
14	Levodopa (L Dopa)FDA LinkGeneric 01/2023 - 05/2002
10	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 12/2022 - 11/2007
6	Amyloid (Amyloid Fibrils)IBA 04/2024 - 10/2015
6	RacloprideIBA 01/2021 - 10/2002
5	Biomarkers (Surrogate Marker)IBA 04/2024 - 11/2011
5	Leucine (L-Leucine)FDA Link 04/2024 - 12/2005
5	Phosphotransferases (Kinase)IBA 04/2024 - 12/2005
5	Oxidopamine (6 Hydroxydopamine)IBA 05/2012 - 09/2006
3	Proteins (Proteins, Gene)FDA Link 05/2024 - 01/2015
3	SynucleinsIBA 05/2024 - 04/2012
3	Amyloid beta-PeptidesIBA 04/2024 - 01/2017
3	Vesicular Monoamine Transport Proteins (Vesicular Monoamine Transporter)IBA 01/2021 - 11/2007
3	Methylphenidate (Ritalin)FDA LinkGeneric 01/2021 - 07/2006
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 10/2013
3	Dihydroxyphenylalanine (Dopa)IBA 01/2019 - 05/2002
3	fluorodopa F 18IBA 01/2017 - 02/2002
2	alpha-SynucleinIBA 01/2022 - 01/2017
2	dihydrotetrabenazineIBA 01/2021 - 01/2020
2	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2021 - 01/2017
2	benzonitrileIBA 01/2021 - 01/2018
2	florbetapirIBA 06/2020 - 10/2019
2	Cholinergic Agents (Cholinergics)IBA 01/2020 - 01/2018
2	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 01/2019 - 01/2019
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2019 - 10/2012
2	Antidepressive Agents (Antidepressants)IBA 01/2018 - 06/2010
2	Serotonin (5 Hydroxytryptamine)IBA 01/2017 - 01/2010
2	setoperoneIBA 06/2010 - 01/2010
2	Antipsychotic Agents (Antipsychotics)IBA 10/2002 - 05/2002
2	Valproic Acid (Depakote)FDA LinkGeneric 10/2002 - 05/2002
1	LigandsIBA 05/2024
1	Glucosylceramidase (Glucocerebrosidase)IBA 09/2023
1	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 12/2022
1	Interleukin-10 (Interleukin 10)IBA 08/2022
1	Haloperidol (Haldol)FDA LinkGeneric 01/2020
1	Dihydrotachysterol (AT 10)IBA 01/2019
1	Quetiapine Fumarate (Seroquel)FDA Link 01/2018
1	3- amino- 4- (2- dimethylaminomethylphenylsulfanyl)benzonitrileIBA 01/2018
1	O-methyl reboxetineIBA 01/2018
1	AcetylcholinesteraseIBA 01/2018
1	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 01/2018
1	dextran-2-hydroxy-3-mercaptopropyl ether (C 79)IBA 10/2017
1	AcidsIBA 01/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	5-fluoroaminosuberic acidIBA 01/2017
1	ProgranulinsIBA 10/2013
1	Phospholipases A2 (Phospholipase A2)IBA 11/2012
1	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 10/2012
1	Amphetamine (Amfetamine)FDA LinkGeneric 10/2012
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 04/2012
1	5-HT2 Serotonin ReceptorsIBA 01/2010
1	levodopa drug combination carbidopa (Nakom)FDA LinkGeneric 12/2004

Therapy/Procedure

7	Therapeutics 01/2020 - 06/2010
6	Denervation 05/2024 - 04/2006
2	Transplantation 08/2005 - 09/2003
1	Radiotherapy 03/2018
1	Deep Brain Stimulation 01/2017
1	Oral Administration 12/2004
1	Aftercare (After-Treatment) 05/2002